Charles and Margaret Lescrenier Lectureship
Thursday, March 7, 2013
Herbert Lepor, MD
Martin Spatz Chairman and Professor
Department of Urology
NYU School of Medicine
Health Sciences Learning Center (HSLC), Room 1335
“Is Minimally Invasive Ablative Therapy of Prostate Cancer Ready for Prime Time?”
Dr. Lepor’s primary clinical and basic research interests are related to the prostate. His clinical practice is currently limited exclusively to surgical management of prostate cancer.
Dr. Lepor has served on the editorial boards for four major urological journals and has authored over 191 peer-reviewed articles, 50 book chapters, and 12 books related to prostate cancer, benign prostatic hyperplasia, and the pharmacology of the prostate. He is the co-founder and editor of Reviews in Urology. Some of Dr. Lepor’s landmark scientific contributions have focused on the identification of the autonomic intervention regulating male sexual function, development of the nerve-sparing radical prostatectomy, improving outcomes following radical retropubic prostatectomy, characterization of the prostate alpha1 adrenoceptor, and the medical and surgical management of benign prostatic hyperplasia.
Dr. Lepor is a member of the American Association of Genitourinary Surgeons, the Clinical Society of the American Association of Genitourinary Surgeons, the American Surgical Association, and the Johns Hopkins University Society of Scholars.
Everyone is welcome to attend the lecture. Please mark your calendars!
The University of Wisconsin School of Medicine and Public Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The University of Wisconsin School of Medicine and Public Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Thursday, March 15
Robert R. Bahnson, MD, FACS
Professor and Chairman
Department of Urology
The Ohio State University
Dr. Bahnson is the recipient of an American Cancer Society Clinical Oncology Career Development Award, an AFUD Research Scholarship, and a Clinical Investigator Award from NIH/NCI to support his research. He served on the Board of Directors of the Northeastern Section and the North Central Section of the AUA. He is a past president of The Ohio Urologic Society and The Society of University Urologists. He has served on the ACGME Residency Review Committee for Urology and currently chairs the Urology Advisory Council for the American College of Surgeons.
Health Sciences Learning Center (HSLC), Room 1325
Multicenter Phase III REDECT trial with 124I-girentuximab-PET/CT for the pre-surgical detection of clear cell Renal Cell Carcinoma (ccRCC)
Thursday, February 24
Hunter Wessells, MD, FACS
Professor and Chair, Department of Urology
University of Washington School of Medicine
Chief of Urology, Harborview Medical Center
Dr. Wessells is a surgeon, researcher and expert on urogenital trauma and erectile dysfunction. His clinical interests cover a wide area of subjects in urology, ranging from acute injury management to sexual complications of diabetes.
Health Sciences Learning Center (HSLC), Room 1309
Urologic Trauma and Reconstruction